Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-16, Stock:JNJ, The news for the past five days is as follows:
2020-12-09: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Markets Book Profits as Vaccine Rally Stalls; DASH Jumps 86% on IPO.NEWS3: Nasdaq Hit Hard After A 1,785-Point Run Since Oct. 30; Will These Top Stocks Break Out?.NEWS4: Former Allergan CEO: Pfizer's $19.50 COVID-19 vaccine dose price 'is a pretty good bargain'.NEWS5: 10 Dividend Stocks Warren Buffett Likes the Most.NEWS6: Heading into Christmas 'we’ll see a spike on top of a spike': Doctor on COVID spread.NEWS7: Moderna Will Succeed, but Its Stock Already Reflects That, Says Needham.NEWS8: IPO Market Set to Thrive in December.NEWS9: 2 Robinhood Stocks That Can Survive Another Market Crash.NEWS10: Curis (CRIS) Skyrockets on Promising Phase I Pipeline Updates.NEWS11: US STOCKS-S&P 500 set for record open on vaccine, stimulus bets.NEWS12: New Investor? Here Are 3 Great Starter Stocks.NEWS13: Is Johnson & Johnson a Great Dividend Stock?.NEWS14: After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?.NEWS15: Corporate America will truly be addressing racial justice when it ‘costs something’: Michael Eric Dyson.NEWS16: Mexico says could order 22 mln more vaccine doses from J&J.NEWS17: Johnson & Johnson Expects Vaccine Trial Results in January.
2020-12-10: NEWS1: Becton Dickinson Expects Covid Testing Sales to Hit $1.5 Billion.NEWS2: Pfizer, BioNTech Nab FDA Panel Recommendation For Covid Vaccine.NEWS3: FDA Committee Nears Key Vote On Pfizer, BioNTech's Covid Vaccine.NEWS4: FDA Committee Takes Up Pfizer, BioNTech Coronavirus Vaccine.NEWS5: Melinda Gates: Half the U.S. could be vaccinated by mid-2021.NEWS6: Melinda Gates: We have a moral responsibility to make sure everybody gets COVID-19 vaccine.NEWS7: This Magic Mushroom Stock Is Worth Your Money Right Now.NEWS8: Pfizer Stock Faces Its Next Big Covid Challenge: An FDA Committee.NEWS9: Forget Moderna! These 2 Stocks May be the Biggest Winners of the Vaccine Race.NEWS10: Oklahoma seeks $9.3 billion from Johnson & Johnson over opioid crisis.
2020-12-11: NEWS1: Government Asks Moderna for More Covid-19 Shots.NEWS2: Pfizer, Biontech vaccine could rollout in U.S. next week.NEWS3: Dow Jones Turns Higher; Did Disney Stock Offer An Extra Buy Point?.NEWS4: Morning Bell With Jim Cramer: Tesla Can Go Higher.NEWS5: This COVID Vaccine Stock Is the Safest Bet of All.
2020-12-14: NEWS1: How one influential billionaire thinks Trump messed up the COVID-19 response.NEWS2: Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?.NEWS3: AstraZeneca’s $39 Billion Takeout of Alexion Wins Tepid Wall Street Approval.NEWS4: Unusual Options Activity Insight: Johnson & Johnson.NEWS5: Coronavirus update: First Pfizer vaccine shots, U.K. to start human challenge trials.NEWS6: COVID-19 Vaccine Race Heats Up as Pfizer Gets Emergency Nod.NEWS7: The Biggest Advantage and Drawback of the Most Promising Coronavirus Vaccines.NEWS8: The Global Energy Association: Ten key ideas in energy.NEWS9: Johnson & Johnson (NYSE:JNJ) Shares Could Be 37% Below Their Intrinsic Value Estimate.
2020-12-15: NEWS1: Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson.NEWS2: 20 Biggest Healthcare Companies By Revenue.NEWS3: Spain's Reig Jofre to manufacture J&J's COVID-19 vaccine in Barcelona.

Answer: Decrease